INNOGENE Co.,Ltd. (KOSDAQ:344860)
South Korea · Delayed Price · Currency is KRW 1,418.00
+143.00 (11.22%)
At close: Jun 30, 2026
INNOGENE Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 9,037 | 8,213 | 8,945 | 10,101 | 9,139 | 9,385 |
Other Revenue | - | - | - | - | - | -0 |
| 9,037 | 8,213 | 8,945 | 10,101 | 9,139 | 9,385 | |
Revenue Growth (YoY) | 4.20% | -8.17% | -11.45% | 10.52% | -2.62% | 66.29% |
Cost of Revenue | 2,828 | 2,023 | 2,325 | 2,781 | 2,363 | 2,069 |
Gross Profit | 6,208 | 6,190 | 6,620 | 7,320 | 6,776 | 7,316 |
Selling, General & Admin | 5,753 | 5,615 | 5,305 | 5,418 | 4,723 | 4,411 |
Research & Development | 281.06 | 279.96 | 413.69 | 429.08 | 326.76 | 308.72 |
Amortization of Goodwill & Intangibles | 26.57 | 17.96 | 5.35 | 2.72 | 14.73 | 24.76 |
Other Operating Expenses | 102.25 | 100.46 | 101.17 | 100.02 | 86.79 | 87.33 |
Operating Expenses | 6,423 | 6,256 | 5,990 | 6,094 | 5,289 | 4,918 |
Operating Income | -214.51 | -65.51 | 630.49 | 1,226 | 1,488 | 2,399 |
Interest Expense | -4.22 | -4.64 | -7.08 | -6.18 | -4.91 | -4.08 |
Interest & Investment Income | 262.35 | 309.03 | 480.1 | 386.35 | 49.62 | 8.13 |
Currency Exchange Gain (Loss) | 28.25 | -5.61 | 11.28 | 9.21 | 6.23 | 9.97 |
Other Non Operating Income (Expenses) | 14.16 | 21.7 | 16.53 | 90.32 | 6.55 | 23.78 |
EBT Excluding Unusual Items | 86.04 | 254.98 | 1,131 | 1,706 | 1,545 | 2,436 |
Gain (Loss) on Sale of Investments | 11.35 | 1.64 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | -8.21 | - | - | - |
Asset Writedown | - | - | - | -0.06 | - | - |
Pretax Income | 97.39 | 256.62 | 1,123 | 1,706 | 1,545 | 2,436 |
Income Tax Expense | -49 | -31.25 | 177.96 | 309.84 | 205.76 | 178.6 |
Net Income | 146.39 | 287.88 | 945.16 | 1,396 | 1,339 | 2,258 |
Net Income to Common | 146.39 | 287.88 | 945.16 | 1,396 | 1,339 | 2,258 |
Net Income Growth | -80.62% | -69.54% | -32.30% | 4.24% | -40.68% | - |
Shares Outstanding (Basic) | 11 | 11 | 12 | 12 | 9 | 9 |
Shares Outstanding (Diluted) | 11 | 11 | 12 | 12 | 9 | 9 |
Shares Change (YoY) | -5.65% | -5.64% | 2.83% | 25.09% | 0.10% | 4345.68% |
EPS (Basic) | 13.08 | 25.50 | 79.00 | 120.00 | 144.00 | 243.00 |
EPS (Diluted) | 13.08 | 25.50 | 79.00 | 120.00 | 144.00 | 243.00 |
EPS Growth | -79.46% | -67.72% | -34.17% | -16.67% | -40.74% | - |
Free Cash Flow | -312.35 | 552.09 | 809.15 | 2,188 | 550.24 | 2,168 |
Free Cash Flow Per Share | -27.92 | 48.91 | 67.63 | 188.08 | 59.16 | 233.31 |
Gross Margin | 68.70% | 75.37% | 74.01% | 72.47% | 74.14% | 77.95% |
Operating Margin | -2.37% | -0.80% | 7.05% | 12.14% | 16.28% | 25.56% |
Profit Margin | 1.62% | 3.50% | 10.57% | 13.82% | 14.65% | 24.06% |
Free Cash Flow Margin | -3.46% | 6.72% | 9.05% | 21.66% | 6.02% | 23.10% |
EBITDA | 34.17 | 176.66 | 856.66 | 1,457 | 1,723 | 2,629 |
EBITDA Margin | 0.38% | 2.15% | 9.58% | 14.42% | 18.85% | 28.01% |
D&A For EBITDA | 248.68 | 242.17 | 226.17 | 230.39 | 235.28 | 230.4 |
EBIT | -214.51 | -65.51 | 630.49 | 1,226 | 1,488 | 2,399 |
EBIT Margin | -2.37% | -0.80% | 7.05% | 12.14% | 16.28% | 25.56% |
Effective Tax Rate | - | - | 15.85% | 18.16% | 13.32% | 7.33% |
Advertising Expenses | - | 1,291 | 1,081 | 904.43 | 788.77 | 584.7 |